HOME >> MEDICINE >> NEWS
UQ scientist honoured for developing the world's first cancer vaccine

s designed for the developing world," he said.

"It will be sold first in the developed world, and of course there is a significant benefit for women in countries with effective Pap smear programs, as abnormal smears will be much less likely after vaccination, but the real need is for the developing world and to have this vaccine used routinely in young women to prevent cervical cancer in countries where there are no Pap smear programs to reduce the risk."

He said both companies involved in the development of the vaccine had indicated that they would introduce a differential pricing structure so developing countries could get the vaccine at a cheaper price.

"But cheaper isn't cheap. This is a vaccine which is technically quite difficult to make," he said.

"It will rely on the good graces of the Gates Foundation, the World Bank and the World Health Organisation's Expanded Vaccine Initiative to make sure this vaccine is made available as cheaply as possible to all the countries in the developing world that want to use it."

Final-stage clinical trials of the vaccine showed it to be 100 percent effective at preventing infection with the types of human papilloma virus (HPV) that are included in the vaccine, which are together responsible for about 70 percent of cervical cancer.

The results of the Phase III trials were announced in October 2005 by international pharmaceutical company Merck & Co. which is developing the product.

"It's very rare, almost unheard of, to achieve a 100 percent efficacy rate in any treatment, so the results are truly wonderful," Professor Frazer said.

"It's the first time in the world that a vaccine designed to prevent cancer has been developed, and it has happened right here in Australia.

"It's very encouraging to see such great results coming out of Australian research, and developed in conjunction with Australian company CSL, and international pharmaceutical compa
'"/>

Contact: Chris Saxby
c.saxby@uq.edu.au
61-733-652-479
Research Australia
23-Jan-2006


Page: 1 2 3

Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. To be or not to be a scientist
3. Barrow scientists make headlines for their research on fixational eye movements
4. UD scientists invent novel hydrogels for repairing, regenerating human tissue
5. UK scientists set their sights on cure for AMD
6. QBI scientist looks at why stroke causes vision problems
7. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
8. Smart mice teach scientists about learning process, brain disorders
9. Why predicting the next influenza pandemic is difficult and how scientists can best prepare
10. Young Australian scientist honored at international meeting
11. Sex and prenatal hormone exposure affect cognitive performance, Yerkes scientists find

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... NY (PRWEB) , ... June 20, 2017 , ... ... their continued expansion and success in the clinical trials market. Similar to its approach ... track record in the clinical trials marketplace by proving the value of eVisits to ...
(Date:6/20/2017)... ... 2017 , ... Dr. Manju R. Kejriwal currently accepts new ... or not they have a referral. Dr. Kejriwal offers state-of-the-art treatment through the ... bacteria and damaged tissue without affecting the surrounding tissue. This technology virtually eliminates ...
(Date:6/20/2017)... ... June 20, 2017 , ... New, state-of-the-art magnetic resonance ... providing physicians with advanced capabilities for diagnosing and treating disease. , Jefferson’s ... doctors to get a more accurate look inside the patient’s body. The new ...
(Date:6/20/2017)... ... 2017 , ... In his newly appointed role as President ... recently accepted the distinguished Sun Corridor Export Award for his company’s global exporting ... 16 other businesses from Pima, Pinal, and Maricopa counties in Arizona, and honored ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... staffing agency, recently became re-accredited by the Joint Commission, which accredits ... Commission accreditation and certification is recognized nationwide as a symbol of quality that ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... ANGELES , June 8, 2017   Responding to ... drug oversight and the death of singer Chris Cornell ... on Human Rights International offers a free online ... better educate consumers and families about psychotropic drug risks. ... Ledger , who died from an accidental overdose, has called ...
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
(Date:6/5/2017)... 2017 Kohll,s Pharmacy & Homecare is the first distributor ... States . The Raizer is a simple battery operated ... to an almost-standing position within a few minutes. ... assistant and does not require any extra effort besides ... child can operate it, and lightweight and portable ...
Breaking Medicine Technology:
Cached News: